Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05276> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05276 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05276 label "hepatitis B immune globulin [drugbank:DB05276]" assertion.
- drugbank:DB05276 seeAlso DB05276 assertion.
- drugbank:DB05276 description "Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. Therefore, the hepatitis-B vaccines are cancer-preventing vaccines. According to the Centers for Disease Control and Prevention (CDC), the hepatitis B vaccine was the first anti-cancer vaccine.[5]" assertion.
- drugbank:DB05276 identifier "drugbank:DB05276" assertion.
- drugbank:DB05276 title "hepatitis B immune globulin" assertion.
- drugbank:DB05276 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05276 drugbank_vocabulary:drugbank-id "DB05276" assertion.
- drugbank:DB05276 bio2rdf_vocabulary:x-identifiers.org DB05276 assertion.
- drugbank:DB05276 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05276" assertion.
- drugbank:DB05276 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05276 bio2rdf_vocabulary:identifier "DB05276" assertion.